HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Richard Fisher Selected Research

tirapazamine (SR 4233)

2/2014Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer.
3/2012Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer.
9/2010Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.
6/2010Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02.
5/2006Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.
12/2005Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent.
1/2005Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Richard Fisher Research Topics

Disease

9Neoplasms (Cancer)
04/2012 - 07/2002
7Head and Neck Neoplasms (Head and Neck Cancer)
02/2014 - 01/2005
6Anoxia (Hypoxia)
02/2014 - 12/2005
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2014 - 06/2010
2Melanoma (Melanoma, Malignant)
09/2015 - 06/2012
2Prostatic Neoplasms (Prostate Cancer)
03/2014 - 11/2004
2Oropharyngeal Neoplasms
06/2011 - 09/2010
2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2007 - 03/2002
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2003 - 07/2002
1Fibrosis (Cirrhosis)
09/2015
1Pain (Aches)
09/2015
1Mental Retardation (Idiocy)
02/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2014
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
05/2013
1Dermatitis
06/2012
1Wound Infection (Wound Infections)
06/2012
1Seroma
06/2012
1Delayed Puberty
05/2011
1Polydactyly (Polydactylism)
05/2011
1Breast Neoplasms (Breast Cancer)
01/2011
1Squamous Cell Neoplasms (Squamous Cell Cancer)
09/2010
1Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2009
1Lymphoma (Lymphomas)
12/2007
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2007
1Rectal Neoplasms (Rectal Cancer)
07/2005
1Radiation Pneumonitis (Radiation Fibrosis)
04/2005
1Lung Neoplasms (Lung Cancer)
04/2005
1Hemorrhage
11/2004
1Neoplasm Metastasis (Metastasis)
01/2003
1Vasculitis (Vasculitides)
06/2002
1Hodgkin Disease (Hodgkin's Disease)
03/2002

Drug/Important Bio-Agent (IBA)

7tirapazamine (SR 4233)IBA
02/2014 - 01/2005
6Cisplatin (Platino)FDA LinkGeneric
02/2014 - 01/2005
4Fluorouracil (Carac)FDA LinkGeneric
02/2014 - 01/2005
3Cyclin-Dependent Kinase Inhibitor p16IBA
03/2012 - 06/2011
2MisonidazoleIBA
02/2014 - 05/2006
2fluoromisonidazoleIBA
05/2006 - 12/2005
1KBG syndromeIBA
02/2015
1rituximab (Mabthera)FDA Link
05/2013
1Etoposide (VP 16)FDA LinkGeneric
05/2013
1iodine-131 anti-B1 antibody (Bexxar)FDA Link
05/2013
1Carmustine (FIVB)FDA Link
05/2013
1trans-crotonin (CTN)IBA
05/2013
1Melphalan (Alkeran)FDA LinkGeneric
05/2013
1Cytarabine (Cytosar-U)FDA LinkGeneric
05/2013
1ChromatinIBA
04/2012
1InterleukinsIBA
03/2012
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
03/2012
1Interleukin-8 (Interleukin 8)IBA
03/2012
1OsteopontinIBA
01/2012
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
06/2011
1Growth Hormone (Somatotropin)IBA
05/2011
1Aromatase InhibitorsIBA
01/2011
1HormonesIBA
01/2011
1bortezomib (Velcade)FDA Link
12/2007
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2007
1CytotoxinsIBA
01/2007
1squamous cell of head and neck CarcinomaIBA
05/2006
1Sucralfate (Carafate)FDA LinkGeneric
11/2004
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
06/2002
1GalliumIBA
03/2002

Therapy/Procedure

14Radiotherapy
09/2015 - 07/2002
3Adjuvant Radiotherapy
09/2015 - 06/2012
2Lymph Node Excision (Lymph Node Dissection)
09/2015 - 06/2012
2Drug Therapy (Chemotherapy)
05/2013 - 12/2005
1Stem Cell Transplantation
04/2014
1Cell Transplantation
05/2013
1Radioimmunotherapy
05/2013
1Transplantation (Transplant Recipients)
05/2013
1Brachytherapy
09/2009
1Anesthesia
10/2003